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Introduction: Persistent genital arousal disorder (PGAD) is the female 
perception that they are in a state of sexual arousal, without the ability of the 
arousal to be satisfied by orgasm. 
Aims: It is the hypothesis of this study that PGAD results from a minimal 
degree of nerve compression of the dorsal branch of the pudendal nerve. If 
this hypothesis were true, then PGAD could be treated by neurolysis of the 
dorsal branch of he pudendal nerve.
Methods: A retrospective chart review was carried out from 2010 through 
2018, of those women having neurolysis of the dorsal branch of the pudendal 
nerve. Patients were included in the cohort if they had a diagnosis of PGAD. 
All patients were assessed for demographic and clinical differences. 
Comparison between the pre-operative and postoperative groups was 
performed with descriptive statistics.
Main Outcome Measures: The changes in clitoral symptoms (arousal, 
numbness, pain) evaluated post-operatively. 
Results: Of the 8 women included in this study, 7 were followed more than 24 
weeks since surgery. Six of these women had the surgery bilaterally, and each 
of these had an excellent result (100%), meaning elimination of the arousal 
symptoms, pain, and the ability to resume normal sexual intercourse. The 
patient with unilateral decompression of the dorsal branch of the pudendal 
nerve had some improvement in arousal symptoms. This patient was the only 
reported case of symptom persistence. 
Clinical Implications: Provides a new treatment approach for patients with 
PGAD.
Strength & Limitations: The main strength of the study is that this is the first 
article to report treatment of PGAD with neurolysis of the dorsal branch of the 
pudendal nerve. The main limitations of the study are the sample size and 
analysis of retrospectively collected data.
Conclusion: The relief of arousal symptoms supports the hypothesis that 





Inclusion criteria were female patients 1) referred for PGAD of more than 52 
weeks duration, who 2) had been treated already by their Gynecologists for all 
known medical causes of this disorder, who 3) have had already pelvic floor 
therapy, who 4) have had a trial of neuropathic pain and anti-anxiety 
medication treatment, and who 5) had stopped any physical activity, such as 
cycling, that may be known to cause compression of the pudendal nerve.
Surgical technique
The patient is placed into lithotomy position, the perineal hairs are clipped 
and a betadine scrub and prep are done. Loupe magnification at 3.5X is 
utilized. A bipolar coagulator is used at the lowest possible voltage, especially 
when dissecting adjacent to the dorsal branch of the pudendal nerve at the 
inferior pubic ramus to avoid electrical injury to the nerve. The local 
anesthetic used is 1% Xylocaine injected into the incision site, which is 
located superior to the ischial tuberosity, and at an angle to the inferior pubic 
ramus, and lateral to the labia majora (Figure 1A). 
The incision is opened into the ischiorectal fossa and maintained open with a 
Weitlander retractor with blunt “teeth.” Dissecting posteriorly and inferiorly, 
the perineal branches are identified, and preserved. In ten percent of patients 
the dorsal branch will exit through the canal of Alcock, 18 and so this variant 
must be identified. If it is present, then the scarring around the exit must be 
released, and this would complete the procedure. This has not proven to be the 
anatomic finding in any of the patients operated on in this series.
After confirming that there is no dorsal pudendal branch exiting the canal of 
Alcock, the Weitlander retractor is placed into the most superior aspect of the 
incision. In this location, the ischiocavernosus muscle is identified and its 
origin from the inferior pubic ramus is released using first the bipolar 
coagulation and then a sharp scissors. Care must be taken not to enter the 
corpora cavernosa to prevent venous bleeding. As the dissection approaches 
the juncture of the inferior pubic ramus with the symphysis pubis, a softer 
region is palpated, and spreading transversely with the scissors reveals a 
yellowish, almost fatty appearing 2 mm diameter dorsal branch of the 
pudendal nerve. Care must be taken not to injure electrically this little nerve. 
The nerve will be in slightly tight fascia as it travels more superficially to the 
base of the clitoris. The nerve will still likely be entrapped by scar more 
proximally. A small right angle clamp or dissector can be placed between the 
nerve and remaining intact fibers of the inferior pubic ramus canal to delineate 
this tight region prior to cauterizing it and then sharply releasing it under 
direct vision while protecting the nerve. (Figure 1B)
The site of compression can often be observed, being narrowed, and often 
inflamed compared to the regions proximal and distal to the compressed nerve 
(Figure 2,3,and 4). 19 
After checking for hemostasis, the wound is closed with interrupted, 
intradermal 4-0 monocryl, and the skin with interrupted and continuous 5-0 
nylon sutures. The dressing is Xeroform, gauze, and small Tegaderm.
MATERIAL AND METHODS
▪Eight women with a mean age of 51 years (standard deviation: 10 years) 
were included (Table 4). Seven of these women had surgery bilaterally. At a 
mean time of 60 weeks following surgery, 7 of the 8 women (88%) had 
complete relief of arousal and 1 (12%) had partial relief following unilateral 
decompression of the dorsal branch of the pudendal nerve. Of the 7 women 
that had pain, 6 (86%) had complete relief after bilateral decompression, and 1 
(14%) had partial relief following unilateral decompression of the dorsal 
branch of the pudendal nerve. No patients reported pre-operative numbness 
for post-operative comparison. Five of the 6 (83%) patients unable to perform 
intercourse without pain were able to perform sexual intercourse without pain 
after surgery. The mean time to improvement of the first symptom following 
surgery was 11 weeks (standard deviation: 11 weeks). No major surgical 
complications were observed. 
RESULTS
CONCLUSION
This is the first report of neurolysis of the dorsal branch of the pudendal nerve 
in women with PGAD. The relief of arousal symptoms supports the 
hypothesis that PGAD is due to a minimal degree of compression of the dorsal 
branch of the pudendal nerve. From the results of this study, it appears that a 
unilateral decompression may not be sufficient to achieve an excellent result 
for patients with PGAD.
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Variables and outcomes analyzed
Primary outcomes measured were pre- and postoperative 1) persistent arousal 
symptoms, 2) pain measured by visual analogue scale, and 3) numbness, with 
changes defined as complete relief (CR), partial relief (PR), or no relief of 
symptoms. Secondary outcomes measured were the change in ability to have 
preoperative and postoperative intercourse. Other secondary measures 
included, mean time to improvement of symptoms following surgery, mean 
length of time for patient follow-up, postoperative complications, and 
symptom recurrence.
Demographics
Table 3 lists the demographics for all 8 women included in this study. 
Variables of interest include: patient age; gender; body mass index (BMI); 
race and ethnicity; if the patient was a current smoker, consumed alcohol or 
recreational drugs; marital status; number of prior gynecological surgeries for 
an unrelated cause; total number of pregnancies; total number of children; 
family history of PGAD or related symptoms; mean number of comorbidities 
per patient; patient comorbidities; patient occupation; the cause of initial 
mechanism of injury; date of first presentation to peripheral nerve specialist, 
mean length of time of PGAD symptoms; mean number of preoperative 
medications to treat PGAD symptoms at first visit. 
The diagnosis of the rare condition, persistent genital arousal disorder 
(PGAD) requires female patients to meet the following five criteria: 1) 
genitals are persistently aroused, 2) arousal remains following orgasm or 
requires multiple orgasms to diminish, 3) arousal is unrelated to desire, 4) 
arousal is triggered by both sexual and non-sexual stimuli, and 5) symptoms 
are intrusive and unwelcomed. 1-3 Unwelcomed or unwanted arousal has been 
observed as the most common detrimental symptom in 91.3% of women 
surveyed in the largest study identifying PGAD symptom characteristics. The 
majority of these women are unable to derive emotional satisfaction from sex.
4 
The hypothesis being tested in this study is that the underlying mechanism 
causing PGAD is a minimal degree of chronic compression of the dorsal 
branch of the pudendal nerve. This is the nerve supplying sensory innervation 
to the clitoris and is often referred as the dorsal nerve to the clitoris. 16 In 
1980, it was reported that a minimal degree of chronic nerve compression was 
interpreted as a hypersensitive response to a vibratory stimulus when applied 
to the ulnar nerve in patients with cubital tunnel syndrome (Table 2). 17 With 
more advanced degrees of nerve compression, there was decreased perception 
of the vibratory stimulus. 17 In 2016, using a rat model of chronic nerve 
compression, it was also observed that the lesser degree of nerve compression 
resulted in a lowering of the sensory (pain withdrawal) response, indicating a 
lower threshold (hypersensitivity) with a minimal degree of nerve 
compression. 10 
The present clinical study evaluates the response of women with PGAD to 
decompression (neurolysis) of the dorsal branch of the pudendal nerve.
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Branch of Pudendal Nerve 
MATERIAL AND METHODS
Ambulation and showering is allowed. The bandage is removed on 
postoperative day #3 and then betadine is applied twice a day. Sutures are 
removed between the 12th and 14th day after surgery.
Rehabilitation consists of water walking in a heated pool, 3 to 4 times per week 
for 15 minutes each time. This can be continued if desired for 3 more weeks, 
increasing to 30 minutes and including swimming.
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